Nilufar Mohebbi
Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?
Kuhn C, Mohebbi N, Ritter A. Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?. Pflugers Arch 2024
Jan 27, 2024Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?
Jan 27, 2024Pflugers Arch 2024
Kuhn Christian, Mohebbi Nilufar, Ritter Alexander
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
Rodríguez D, Gurevich E, Mohammadi Jouabadi, Pastor Arroyo E, Ritter A, Estoppey Younes S, Wagner C, Imenez Silva P, Seeger H, Mohebbi N. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria. Clinical Kidney Journal 2023
Nov 1, 2023Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
Nov 1, 2023Clinical Kidney Journal 2023
Rodríguez Daniel, Gurevich Ekaterina, Mohammadi Jouabadi Soroush, Pastor Arroyo Eva Maria, Ritter Alexander, Estoppey Younes Sandrine, Wagner Carsten A, Imenez Silva Pedro H, Seeger Harald, Mohebbi Nilufar
Bicarbonate ineffectiveness for kidney transplant - Authors' reply.
Mohebbi N, Ritter A. Bicarbonate ineffectiveness for kidney transplant - Authors' reply. Lancet 2023; 402:1528.
Oct 28, 2023Bicarbonate ineffectiveness for kidney transplant - Authors' reply.
Oct 28, 2023Lancet 2023; 402:1528
Mohebbi Nilufar, Ritter Alexander
Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
Legay C, Haeusermann T, Pasquier J, Chatelan A, Fuster D, Dhayat N, Seeger H, Ritter A, Mohebbi N, Ernandez T, Stoermann-Chopard C, Buchkremer F, Segerer S, Wuerzner G, Ammor N, Roth B, Wagner C, Bonny O, Bochud M. Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort. J Ren Nutr 2023; 33:555-565.
Apr 27, 2023Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
Apr 27, 2023J Ren Nutr 2023; 33:555-565
Legay Constance, Haeusermann Tanja, Pasquier Jérôme, Chatelan Angeline, Fuster Daniel G, Dhayat Nasser A, Seeger Harald, Ritter Alexander, Mohebbi Nilufar, Ernandez Thomas, Stoermann-Chopard Catherine, Buchkremer Florian, Segerer Stephan, Wuerzner Gregoire, Ammor Nadia, Roth Beat, Wagner Carsten A, Bonny Olivier, Bochud Murielle
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat N, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin R, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti G, Trelle S, Fuster D. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. N Engl J Med 2023; 388:781-791.
Mar 2, 2023Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Mar 2, 2023N Engl J Med 2023; 388:781-791
Dhayat Nasser A, Bonny Olivier, Roth Beat, Christe Andreas, Ritter Alexander, Mohebbi Nilufar, Faller Nicolas, Pellegrini Lisa, Bedino Giulia, Venzin Reto M, Grosse Philipp, Hüsler Carina, Koneth Irene, Bucher Christian, Del Giorno Rosaria, Gabutti Luca, Mayr Michael, Odermatt Urs, Buchkremer Florian, Ernandez Thomas, Stoermann-Chopard Catherine, Teta Daniel, Vogt Bruno, Roumet Marie, Tamò Luca, Cereghetti Grazia M, Trelle Sven, Fuster Daniel G
The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
Bonny O, Fuster D, Seeger H, Ernandez T, Buchkremer F, Wuerzner G, Dhayat N, Ritter A, Stoermann-Chopard C, Segerer S, Haeusermann T, Pasch A, Kim M, Mayr M, Krapf R, Roth B, Bochud M, Mohebbi N, Wagner C. The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland. Kidney Blood Press Res 2023
Feb 13, 2023The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
Feb 13, 2023Kidney Blood Press Res 2023
Bonny Olivier, Fuster Daniel G, Seeger Harald, Ernandez Thomas, Buchkremer Florian, Wuerzner Gregoire, Dhayat Nasser A, Ritter Alexander, Stoermann-Chopard Catherine, Segerer Stephan, Haeusermann Tanja, Pasch Andreas, Kim Minjeong, Mayr Michael, Krapf Reto, Roth Beat, Bochud Murielle, Mohebbi Nilufar, Wagner Carsten A
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
Mohebbi N, Ritter A, Wiegand A, Graf N, Dahdal S, Sidler D, Arampatzis S, Hadaya K, Müller T, Wagner C, Wüthrich R. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401:557-567.
Jan 25, 2023Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
Jan 25, 2023Lancet 2023; 401:557-567
Mohebbi Nilufar, Ritter Alexander, Wiegand Anna, Graf Nicole, Dahdal Suzan, Sidler Daniel, Arampatzis Spyridon, Hadaya Karine, Müller Thomas F, Wagner Carsten A, Wüthrich Rudolf P
Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance.
Imenez Silva P, Wiegand A, Daryadel A, Russo G, Ritter A, Gaspert A, Wüthrich R, Wagner C, Mohebbi N. Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance. Nephrol Dial Transplant 2021; 36:1806-1820.
Sep 27, 2021Acidosis and alkali therapy in patients with kidney transplant is associated with transcriptional changes and altered abundance of genes involved in cell metabolism and acid-base balance.
Sep 27, 2021Nephrol Dial Transplant 2021; 36:1806-1820
Imenez Silva Pedro H, Wiegand Anna, Daryadel Arezoo, Russo Giancarlo, Ritter Alexander, Gaspert Ariana, Wüthrich Rudolf P, Wagner Carsten A, Mohebbi Nilufar
Recurrent Nephrolithiasis in a Patient With Hypercalcemia and Normal to Mildly Elevated Parathyroid Hormone.
Ritter A, Vargas-Poussou R, Mohebbi N, Seeger H. Recurrent Nephrolithiasis in a Patient With Hypercalcemia and Normal to Mildly Elevated Parathyroid Hormone. Am J Kidney Dis 2021; 77:A13-A15.
Jun 1, 2021Recurrent Nephrolithiasis in a Patient With Hypercalcemia and Normal to Mildly Elevated Parathyroid Hormone.
Jun 1, 2021Am J Kidney Dis 2021; 77:A13-A15
Ritter Alexander, Vargas-Poussou Rosa, Mohebbi Nilufar, Seeger Harald
Causes and Consequences of Metabolic Acidosis in Patients after Kidney Transplantation.
Ritter A, Mohebbi N. Causes and Consequences of Metabolic Acidosis in Patients after Kidney Transplantation. Kidney Blood Press Res 2020; 45:792-801.
Oct 9, 2020Causes and Consequences of Metabolic Acidosis in Patients after Kidney Transplantation.
Oct 9, 2020Kidney Blood Press Res 2020; 45:792-801
Ritter Alexander, Mohebbi Nilufar
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dhayat N, Faller N, Bonny O, Mohebbi N, Ritter A, Pellegrini L, Bedino G, Schönholzer C, Venzin R, Hüsler C, Koneth I, Del Giorno R, Gabutti L, Amico P, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Rintelen F, Roumet M, Irincheeva I, Trelle S, Tamò L, Roth B, Vogt B, Fuster D. Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC Nephrol 2018; 19:349.
Dec 10, 2018Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dec 10, 2018BMC Nephrol 2018; 19:349
Dhayat Nasser A, Faller Nicolas, Bonny Olivier, Mohebbi Nilufar, Ritter Alexander, Pellegrini Lisa, Bedino Giulia, Schönholzer Carlo, Venzin Reto M, Hüsler Carina, Koneth Irene, Del Giorno Rosaria, Gabutti Luca, Amico Patrizia, Mayr Michael, Odermatt Urs, Buchkremer Florian, Ernandez Thomas, Stoermann-Chopard Catherine, Teta Daniel, Rintelen Felix, Roumet Marie, Irincheeva Irina, Trelle Sven, Tamò Luca, Roth Beat, Vogt Bruno, Fuster Daniel G
Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.
Wiegand A, Ritter A, Graf N, Arampatzis S, Sidler D, Hadaya K, Müller T, Wagner C, Wüthrich R, Mohebbi N. Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol. BMC Nephrol 2018; 19:177.
Jul 13, 2018Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.
Jul 13, 2018BMC Nephrol 2018; 19:177
Wiegand Anna, Ritter Alexander, Graf Nicole, Arampatzis Spyridon, Sidler Daniel, Hadaya Karine, Müller Thomas F, Wagner Carsten A, Wüthrich Rudolf P, Mohebbi Nilufar
Rezidivprophylaxe bei Nierensteinleiden
Ritter A, Mohebbi N, Seeger H. Rezidivprophylaxe bei Nierensteinleiden. Hausarzt Praxis, Fortschritte der Medizin 2018:26-31.
Apr 19, 2018Rezidivprophylaxe bei Nierensteinleiden
Apr 19, 2018Hausarzt Praxis, Fortschritte der Medizin 2018:26-31
Ritter Alexander, Mohebbi Nilufar, Seeger Harald